Residential College | false |
Status | 已發表Published |
LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells | |
Zhao,Xian1; Wang,Yanli1; He,Jianfeng1; Deng,Rong1; Huang,Xiaojun2![]() ![]() ![]() ![]() | |
2020-08-17 | |
Source Publication | MOLECULAR CARCINOGENESIS
![]() |
ISSN | 0899-1987 |
Volume | 59Issue:10Pages:1174-1187 |
Abstract | Long noncoding RNAs (LncRNAs) have emerged as important players in cancer biology. Increasing evidence suggests that LncRNAs are frequently dysregulated in cancer and may function as oncogenes or tumor suppressors. Urothelial carcinoma associated 1 (UCA1), a LncRNA, firstly identified in bladder transitional cell carcinoma, seems to act as an oncogene in many different types of human cancers by promoting cell proliferation and migration. In this study, we revealed a novel biological function of UCA1, which was different from that reported by previous studies, was responsible for maintaining the low-tumorigenic, nonmetastatic phenotypes in primary prostate epithelial cells. UCA1 could stabilize E-cadherin protein by preventing the interaction between E-cadherin and its E3 ligase MDM2, which suppressed MDM2-mediated ubiquitination and degradation of E-cadherin. In addition, we also found that UCA1 acted as a sponge of miR-296-3p, which targeted E-cadherin gene CDH1 messenger RNA at the posttranscription level. Taken together, these findings demonstrated that UCA1 had a new important role in effectively keeping E-cadherin at a high level through a dual mechanism, which maintained primary prostate cancer cells at the low-tumorigenic and nonmetastatic status. |
Keyword | E-cadherin Lncrna Uca1 Mdm2 Mir-296-3p Primary Prostate Cancer Cells |
DOI | 10.1002/mc.23247 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Biochemistry & Molecular Biology ; Oncology |
WOS Subject | Biochemistry & Molecular Biology ; Oncology |
WOS ID | WOS:000559881300001 |
Publisher | WILEY111 RIVER ST, HOBOKEN 07030-5774, NJ |
Scopus ID | 2-s2.0-85089442643 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Institute of Translational Medicine Faculty of Health Sciences |
Corresponding Author | Xie,Ruiyu; Yu,Jianxiu |
Affiliation | 1.Department of Biochemistry and Molecular Cell Biology,Shanghai Key Laboratory of Tumor Microenvironment and Inflammation,State Key Laboratory of Oncogenes and Related Genes,Shanghai Jiao Tong University School of Medicine,Shanghai,China 2.Faculty of Health of Sciences,Institute of Translational Medicine,University of Macau,Macao 3.Basic Clinical Research Center,School of Medicine,Renji Hospital,Shanghai Jiao Tong University,Shanghai,China |
Corresponding Author Affilication | University of Macau |
Recommended Citation GB/T 7714 | Zhao,Xian,Wang,Yanli,He,Jianfeng,et al. LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells[J]. MOLECULAR CARCINOGENESIS, 2020, 59(10), 1174-1187. |
APA | Zhao,Xian., Wang,Yanli., He,Jianfeng., Deng,Rong., Huang,Xiaojun., Guo,Yanmin., Li,Lian., Xie,Ruiyu., & Yu,Jianxiu (2020). LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells. MOLECULAR CARCINOGENESIS, 59(10), 1174-1187. |
MLA | Zhao,Xian,et al."LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells".MOLECULAR CARCINOGENESIS 59.10(2020):1174-1187. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment